Refractive outcomes after silicone oil removal and intraocular lens implantation.

Purpose: To evaluate the accuracy of intraocular lens (IOL) calculations in eyes undergoing silicone oil removal and IOL implantation using ultrasound biometry and partial coherence interferometry (PCI) (IOLMaster).

Methods: This was a retrospective consecutive series of eyes that underwent silicone oil removal and IOL implantation from 1999 to 2009. Data were collected on preoperative and intraoperative characteristics that could affect the refractive outcome.

Management options for submacular perfluorocarbon liquid.

Background And Objective: To report the anatomic and visual outcomes of patients with retained submacular perfluorocarbon liquid (PFCL).

Patients And Methods: A retrospective observational case series of patients with retained submacular PFCL. The medical and surgical records of 8 eyes of 8 patients with retained submacular PFCL after complex retinal detachment repair were reviewed.

Retinal detachment despite aggressive management of aggressive posterior retinopathy of prematurity.

Posterior retinopathy of prematurity (ROP) is unusual in its atypical features and its aggressive, rapidly progressive course. It is more difficult to recognize and to treat, with many of these eyes progressing to retinal detachment despite multiple treatments with laser or cryotherapy. The authors present a case of aggressive posterior ROP refractory to multiple laser treatment.

Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model.

Background: Recombinant human erythropoietin (rhEPO) is used for the treatment of anemia of prematurity. However, it has also been found to have properties similar to vascular endothelial growth factor (VEGF), the major angiogenic factor implicated in the pathogenesis of retinopathy of prematurity (ROP). We sought to determine whether rhEPO is an independent risk factor for the development of ROP.